| Adriana Laser, MD | |
|
391 Myrtle Ave Ste 5, Albany, NY 12208-3797 | |
| (518) 262-5640 | |
| Not Available |
| Full Name | Adriana Laser |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 17 Years |
| Location | 391 Myrtle Ave Ste 5, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073716049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 283562 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Ellis Hospital | Schenectady, NY | Hospital |
| St Mary's Healthcare | Amsterdam, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Medical College | 1759293111 | 910 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
| Entity Name | The Vascular Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124018478 PECOS PAC ID: 2365436649 Enrollment ID: O20040409000569 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891277000 PECOS PAC ID: 1759293111 Enrollment ID: O20190102000038 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adriana Laser, MD 391 Myrtle Ave Ste 5, Albany, NY 12208-3797 Ph: (518) 262-5640 | Adriana Laser, MD 391 Myrtle Ave Ste 5, Albany, NY 12208-3797 Ph: (518) 262-5640 |
News Archive
IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of several established branded atypical antipsychotics will cause the schizophrenia drug market to decrease from $6.3 billion in 2008 to $5.2 billion in 2013 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.
Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.
› Verified 1 days ago
Dr. Todd Beyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Carl Rosati, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. John B Waldman, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5088 Fax: 518-262-5400 | |
Dr. Andrew L Isenberg, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 304, Albany, NY 12208 Phone: 518-525-5206 | |
Dr. Edward Choongho Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-5623 Fax: 518-262-5560 | |
Dr. Elizabeth Robison, MD Surgery Medicare: Medicare Enrolled Practice Location: 113 Holland Ave, Mail Code 112, Albany, NY 12208 Phone: 518-626-6588 Fax: 518-626-6606 |